Iron stores, hepcidin, and aortic stiffness in individuals with hypertension by L. Valenti et al.
RESEARCH ARTICLE
Iron Stores, Hepcidin, and Aortic Stiffness in
Individuals with Hypertension
Luca Valenti1*, Alessandro Maloberti2, Stefano Signorini3, Marta Milano1,
Francesca Cesana2, Fabrizio Cappellini3, Paola Dongiovanni1, Marianna Porzio1,
Francesco Soriano2, Maura Brambilla3, Giancarlo Cesana4, Paolo Brambilla3,
Cristina Giannattasio2☯, Silvia Fargion1☯
1 Internal Medicine and Metabolic Diseases, Fondazione IRCCS Ca’Granda Ospedale Policlinico,
Università degli Studi di Milano, Milan, Italy, 2 Cardiology IV, De Gasperi Department, Niguarda Ca’Granda
Hospital, and Medicine Department, UniversitàMilano Bicocca, Milan, Italy, 3 Laboratory Medicine, Desio
Hospital, UniversitàMilano Bicocca, Milan, Italy, 4 General Direction, Fondazione IRCCS Ca’Granda
Ospedale Policlinico, Research Centre on Public Health, University Milano Bicocca, Milan, Italy




Iron accumulation within the arterial wall has been hypothesized to promote atherosclerosis
progression. Aim of this study was to evaluate whether the hormone hepcidin and iron
stores are associated with arterial stiffness in subjects with essential hypertension.
Methods
Circulating hepcidin, ferritin, and mutations in the hemochromatosis gene were compared
between subjects included in the first vs. third tertile (n=284 each) of carotid-femoral pulse
wave velocity (PWV) in an unselected cohort of patients with arterial hypertension.
Results
At univariate logistic regression analysis, high PWV was associated with higher ferritin lev-
els (p=0.010), but lower hepcidin (p=0.045), and hepcidin ferritin/ratio (p<0.001). Hemo-
chromatosis mutations predisposing to iron overload were associated with high PWV
(p=0.025). At multivariate logistic regression analysis, high aortic stiffness was associated
with older age, male sex, lower BMI, higher systolic blood pressure and heart rate, hyperfer-
ritinemia (OR 2.05, 95% c.i. 1.11-3.17 per log ng/ml; p=0.022), and lower circulating hepci-
din concentration (OR 0.29, 95% c.i. 0.16-0.51 per log ng/ml; p<0.001). In subgroup
analyses, high PWV was associated with indices of target organ damage, including micro-
albuminuria (n=125, p=0.038), lower ejection fraction (n=175, p=0.031), cardiac diastolic
dysfunction (p=0.004), and lower S wave peak systolic velocity (p<0.001). Ferritin was
associated with cardiac diastolic dysfunction, independently of confounders (p=0.006).
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Conclusions
In conclusion, hyperferritinemia is associated with high aortic stiffness and cardiac diastolic
dysfunction, while low circulating hepcidin with high aortic stiffness.
Introduction
Atherosclerosis, the leading cause of cardiovascular disease and mortality worldwide, is a
chronic inflammatory disease characterized by the progressive formation of neo-intimal lesions
and lumen narrowing of affected arteries. Development of atherosclerotic lesions is caused by
retention of low-density lipoprotein cholesterol within arterial intima, favored by activation of
immune cells with induction of oxidative stress [1]. Hypercholesterolemia, arterial hyperten-
sion, cigarette smoke, and hyperglycemia, that is the classic cardiovascular risk factors, are
major driver of atherogenesis.
Arterial stiffness, a physical phenotype of the vascular wall, can be estimated by measure-
ment of aortic pulse wave velocity (PWV) [2]. PWV reflects the advancement of atherosclero-
sis, and is an independent predictor of cardiovascular disease [3, 4]. Mechanisms linking
arterial stiffness with cardiovascular risk are related to the effect on cardiac afterload increasing
cardiac work, and the promotion of target organ damage by facilitation of the transmission of
pulse waves to the microcirculation [5, 6]. Blood pressure and aging are established factors con-
tributing to arterial stiffening, but inflammation may be involved through induction of oxida-
tive stress [7].
However, even in patients with hypertension there is a great variability in the progression
of arterial damage, and in a considerable proportion of cases vascular disease is not fully
explained by classic risk factors. Iron accumulation in macrophages within the arterial wall has
been hypothesized to represent a novel determinant of atherosclerosis progression by inducing
oxidative stress and the release of proinflammatory mediators [8, 9]. Indeed, excess body iron
stores are frequently detected in subjects with insulin resistance and related metabolic alter-
ations [10]. Furthermore, circulating ferritin, a marker of iron accumulation and inflammation,
has been linked with increased risk of carotid plaques development [11]. The hepatic hormone
hepcidin regulate body iron fluxes by determining intracellular retention of this metal and
reduced intestinal absorption by downregulation of the cellular exporter Ferroportin-1 [12].
Hepcidin secretion is induced by elevated body iron stores and inflammation [13]. Therefore,
hepcidin may favor atherosclerosis by determining iron trapping within macrophages in ath-
erosclerotic plaques [8]. In keeping with this hypothesis, circulating hepcidin levels correlated
with the macrophage chemokine CCL2 and common carotid arteries intima media thickness
(CCA-IMT) in individuals with metabolic syndrome alterations [14]. On the other hand, hep-
cidin may also exert anti-inflammatory activities [15].
Aim of this study was therefore to evaluate whether body iron stores and circulating hepci-
din are associated with arterial stiffness in individuals with arterial hypertension.
Materials and Methods
Study design
The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki,
and was approved by Institutional Ethics Review Committees of the Institution involved
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(Fondazione IRCCS Ca' Granda Ospedale Policlinico and Università degli Studi Milano
Bicocca, all in Milan Italy). All participants provided informed written consent.
Aim of the study was to evaluate whether serum hepcidin and iron stores were associated
with high vs. low PWV (third vs. first tertile) in a previously described cohort of 827 consecu-
tive unselected patients with arterial hypertension for whom serum and DNA samples are
available [16].
Patients
From September 2006 to October 2008 827 consecutive outpatients aged 18–80 years old, fol-
lowed at the Hypertension Center of San Gerardo Hospital, Monza, Italy, for essential hyper-
tension with adequate blood pressure control were enrolled.
For the purpose of this study, subjects in the upper and lower PWV tertiles were selected,
obtaining two groups of 284 subjects each. Exclusion criteria were age younger than 18 years
old, pregnancy, secondary hypertension, stage 4–5 chronic kidney and advanced pulmonary
disease, substance abuse, a history of cancer or of cardiovascular events in the month before
the study.
For all subjects, a comprehensive medical history was collected and complete physical
examination was performed. Height and weight were obtained to calculate the patient body
mass index (BMI) and waist circumference was assessed halfway between the lower ribs and
the iliac crest. Fasting serum glucose, total cholesterol, high-density lipoprotein (HDL), low-
density lipoprotein (LDL) cholesterol, triglycerides, creatinine, interleukin-18 (IL-18), Serum
Amyloid A (SAA) e High Sensitivity C-reactive Protein (CRP) were measured.
Measurement of pulse wave velocity (PWV)
Aortic stiffness was evaluated by estimating PWV between the ipsilateral carotid and the
femoral arteries with the patient in the supine position. The pressure pulse waveforms were
simultaneously obtained at the two arterial sites on the right side using an automatic device
(Complior, Colson; AlamMedical, Paris, France) and their distance (between the hip and
neck) calculated by a rigid ruler. Measure was corrected by a 0.8 factor accordingly to the PWV
measurement methods consensus document [17].
The mean of two acquisitions was used for the analysis. The intra-session within- and
between- operator variability of PWV were 2% and to 4%, respectively. The corresponding
value for the inter-session between- operator variability was 4% [16].
Hepcidin, ferritin and cytokines measurement
Hepcidin-25 serum levels were measured by Liquid Chromatography-Mass Spectrometry
(LC-MS) on the LTQ analyzer (Thermo Scientific). The limit of detection (LOD) and limit of
quantitation (LOQ) were 0.5 ng/mL and 1.0 ng/mL, respectively. Linearity of quantification
was confirmed in the following range: 1.– 500 ng/mL.
Serum Ferritin was measured by the COBAS 8000 automated analyzer (Roche Diagnostics)
by ECLIA (Electro-Chemiluminescence ImmunoAssay) (LOD = 0.50 ng/mL, linearity 0.5–
2000 ng/mL). Hyperferritinemia was defined as ferritin levels higher than 240 ng/ml in females
and 320 ng/ml in males (reference values for the Italian population).
Serum IL-6 and IL-18 were measured by BEP 2000 the automatic analyzer (Siemens Diag-
nostics) by ELISA, SAA by immunonephelometry (N Latex SAA, sensitivity 0.7 mg/L) by the
BN II Analyzer (Siemens Diagnostics), hs-PCR was measured by the COBAS 8000 automated
analyzer (Roche Diagnostics) by immunoturbidimetry.
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Evaluation of target organ damage
Proteinuria was quantified in a subset of 126 subjects (65 in the upper and 61 in the lower
PWV tertiles) on urines collected in the preceding 24 hours.
CCA-IMT was measured in a subgroup of 175 individuals (85 in the upper and 90 in the
lower PWV tertiles). With the subject supine and the neck in partial extension, right CCA was
scanned by the Philips Sonos 5500 ultrasonography device [18]. Two-dimensional echocardio-
grams were performed by an experienced cardiologist using a dedicated ultrasound machine
(SONOS 5500; Philips Healthcare, MA, USA with an ultrasound transducer of 2.5MHz.). The
following parameters were recorded: left ventricular end-diastolic diameter, inter-ventricular
septum, posterior wall thickness and ejection fraction by the Simpson method., left ventricular
mass (calculated using the Deveraux formula). Pulsed Doppler was placed on the mitral anulus
and the trans-mitral flow was evaluated in order to measure diastolic function parameters (E/A
ratio: early/atrial component of ventricular filling). Two-dimensional loops with the superim-
posed color-coded tissue doppler images map of four-chamber views with pulsed doppler sig-
nal on the later left ventricular wall was used for the analysis of the later wall motion signal and
to measure absolute values of longitudinal velocity (i.e. the peak systolic velocity S').
Genetic analysis
DNA was extracted from peripheral blood by phenol—chloroform method. Success rate in
extracting DNA was 100% for each study group. HFE genotype (C282Y and H63D variants)
was assessed by sequence allele specific PCR as previously described [19]. Random samples
were confirmed by direct sequencing. Quality controls were performed to verify the reproduc-
ibility of the results. Valid genotypic data were obtained for the totality of subjects analyzed.
Presence ofHFE genotypes at risk of iron overload was defined according to previous literature
data [20].
Statistical analysis
For descriptive statistics, continuous traits were summarized as means±SD. Highly skewed var-
iables—such as circulating hepcidin-25 and ferritin concentration—were summarized as medi-
ans and interquartile range. Categorical variables are shown as percentages. Analyses were
performed by fitting data to generalized linear regression models. Logistic regression models
were fit to examine binary traits (high vs. low PWV). Hepcidin and ferritin levels were log-
transformed before entry into the models.
Statistical analyses were carried out with JMP 11.0 (SAS Institute, Cary, NC). A two-sided P
value<0.05 was considered statistically significant.
Results
Clinical features of individuals with hypertension according to arterial
stiffness
The clinical features of patients stratified according to PWV tertiles (third vs. first tertile) are
shown in Table 1. As expected, subjects with high stiffness had thicker CCA-IMT, older age,
were more frequently males and active smokers, had larger abdominal circumference, higher
SBP and heart rate, and among inflammatory markers, higher interleukin-18 levels (p<0.05).
At multivariate logistic regression analysis corrected for demographic features (age and sex),
only age, sex, SBP, and heart rate remained associated with high PWV.
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Iron parameters and hepcidin determinants
Iron parameters according to PWV tertiles are shown in Table 2. Ferritin and hepcidin levels
were generally within the normal range, and the frequency distribution of HFE genotypes
(reported in S1 Table) were in line with the expected prevalence in Northern Italy and did not
violate Hardy-Weinberg equilibrium.
As expected, the hepcidin/ferritin ratio was lower in patients carryingHFE genotypes at risk
of iron overload (0.10, IQR 0.07–0.21 vs. 0.22, IQR 0.11–0.41 ng/ml; p = 0.001). Independent
predictors of hepcidin levels at multivariate generalized linear model are shown in Table 3 and
in Fig 1. Ferritin was the main determinant of hepcidin levels also in the present cohort of
patients with hypertension (estimate per 1 log increase 1.60±0.07; p<0.001), but no other inde-
pendent predictors could be identified. In particular, ferritin was not significantly associated
with any inflammatory marker.
Association of iron parameters with arterial stiffness
At univariate logistic regression analysis (Table 2, left panel), high stiffness was associated with
higher ferritin levels (p = 0.010), but lower hepcidin (p = 0.045), and lower hepcidin/ferritin
Table 1. Clinical features of 568 Italian patients with essential hypertension stratified according to common carotid arteries stiffness (third vs. first
tertile).
Stiffness
High (n = 284) Low (n = 284) OR (95% CI) p OR (95% CI)* p*
PWV, m/sec 10±2.5 7.4±1.6 2.40 (2.08–2.80) <0.001 2.12 (1.84–2.49) <0.001
CCA-IMT, mm ^ 0.8 ± 0.2 0.7 ± 0.2 19.4 (3.1–146) 0.001 12.6 (0.60–47) 0.14
Age, per 10 years 63±11 53±11 2.38 (2.00–2.88) <0.001 2.44 (2.04–2.96) <0.001
Sex, male 182 (64) 139 (49) 1.88 (1.34–2.63) <0.001 1.96 (1.35–2.87) <0.001
Currently smoking, yes 32 (11) 47 (17) 0.57 (0.36–0.91) 0.019 0.67 (0.37–1.12) 0.13
Waistline, cm 96±12 94±13 1.02 (1.00–1.03) 0.025 1.00 (0.99–1.01) 0.82
BMI, Kg/m2 27±4 27±5 0.97 (0.83–1.01) 0.21 0.96 (0.91–1.01) 0.10
Hb, g/dl 13.9±2.2 13.7±2.7 1.06 (0.82–1.36) 0.42 0.98 (0.77–1.22) 0.86
Glucose, mg/dl 101±22 94±28 1.00 (0.99–1.01) 0.12 1.00 (0.99–1.01) 0.31
Triglycerides, mg/dl 112±59 95±47 1.01 (1.00–1.01) 0.064 1.01 (1.00–1.01) 0.11
Total cholesterol, mg/dl 194 ± 36 197 ± 33 1.00 (0.99–1.01) 0.60 1.00 (1.00–1.00) 0.65
HDL, mg/dl 55±18 58±14 0.99 (0.97–1.01) 0.36 1.00 (0.97–1.02) 0.93
SBP, per 10 mmHg 140±21 126±19 1.04 (1.03–1.05) <0.001 1.03 (1.02–1.05) <0.001
DBP, mmHg 80±14 79±13 1.01 (0.99–1.02) 0.29 1.02 (1.00–1.03) 0.007
Heart rate, bpm 72±12 71±13 1.01 (1.00–1.02) 0.10 1.03 (1.01–1.05) <0.001
IL18, pg/ml 243 {187–308} 219 {175–280} 3.91° (1.56–10.1) 0.004 1.03° (0.35–3.03) 0.97
SAA, mg/l 5.3 {3.2–8.4} 5.4 {3.6–9.2} 0.88° (0.57–1.35) 0.56 0.90° (0.56–1.47) 0.68
hs-CRP, mg/l 1.4 {0.7–3.3} 1.6 {0.8–3.9} 0.82 (0.58–1.16) 0.26 0.90 (0.60–1.37) 0.59
Data are shown as means±SD, prevalence (% value), median {interquartile range}, as required. CCA: common carotid arteries; PWV: pulse wave veIocity;
IMT: intima-media thickness, HDL: high-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; bpm: beats per
minute; IL18: interleukin-18, SAA: serum amyloid A protein, hs-CRP: high sensitivity C reactive protein. Comparisons were made by ﬁtting data to logistic
regression models. OR: odds ratio for high vs. low CCA stiffness; CI: conﬁdence intervals.
*Adjusted for age and sex.
^Available in 175 individuals.
° per 1 log increase.
doi:10.1371/journal.pone.0134635.t001
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ratio (p<0.001). The presence ofHFE genotypes predisposing to iron overload was associated
with high PWV (p = 0.025).
At multivariate logistic regression analysis corrected for age and sex (Table 2, right panel),
lower hepcidin (p<0.001), lower hepcidin/ferritin ratio (p = 0.01), and HFE genotypes at risk
of iron overload (p = 0.041) remained associated with high PWV.
Independent predictors of arterial stiffness
Independent predictors of high PWV at multivariate logistic regression analysis are shown in
Table 4. In the full model adjusted for the independent determinants identified above, high
aortic stiffness was associated with older age, male sex, lower BMI, higher SBP and heart rate,
hyperferritinemia (OR 2.05, 95% c.i. 1.11–3.17 per log ng/ml; p = 0.022), and lower circulating
hepcidin (OR 0.29, 95% c.i. 0.16–0.51 per log ng/ml; p<0.001). The association between hepci-
din and high arterial stiffness was significant both in males (adjusted OR 0.35, 95% c.i. 0.17–
0.68 per log ng/ml; p = 0.002), and in females (adjusted OR 0.33, 95% c.i. 0.12–0.88 per log ng/
ml; p = 0.026). Independent determinants of PWV in patients stratified by the presence of type
2 diabetes mellitus (T2DM) are shown in S2 Table. In patients without T2DM (n = 498), high
PWV remained borderline associated with hyperferritinemia (adjusted OR 1.96, 95% c.i. 1.00–
3.94; p = 0.05) and associated with hepcidin (adjusted OR 0.26, 95% c.i. 0.13–0.48 per log ng/
ml; p<0.001).
Table 3. Predictors of circulating hepcidin in 568 patients with arterial hypertension.We included variables available for all patients evaluated, when
p0.10 for association with ferritin levels at univariate analysis.
Estimate SE p value Estimate* SE* p value*
Age, per 10 years +0.03 0.01 0.025 -0.02 0.02 0.28
Sex, male +0.04 0.01 0.019 +0.01 0.01 0.31
IL18, log pgml +0.15 0.09 0.10 -0.04 0.09 0.68
Ferritin, log ng/ml +0.31 0.04 <0.001 - - -
Comparisons were made by ﬁtting data to generalized linear models. OR: odds ratio; c.i.: conﬁdence interval;
* Adjusted for serum ferritin.
doi:10.1371/journal.pone.0134635.t003
Table 2. Iron status in 568 Italian patients with essential hypertension stratified according to common carotid arteries stiffness (third vs. first
tertile).
Stiffness
High (n = 284) Low (n = 284) OR (95% CI) p OR (95% CI)* p*
Ferritin, ng/ml 152 {82–269} 137 {60–141} 1.63° (1.13–2.83) 0.010 0.94° (0.57–1.55) 0.82
Hyperferritinemia, yes 53 (20) 36 (13) 1.53 (1.00–2.50) 0.05 1.20 (0.70–2.06) 0.52
Hepcidin, ng/ml 27 {13–49} 32 {15–59} 0.64° (0.41–0.99) 0.045 0.39° (0.23–0.65) <0.001
Hepcidin/ferritin, ratio 0.18 {0.09–0.35} 0.27 {0.13–0.48} 0.73° (0.61–0.87) <0.001 0.77° (0.63–0.94) 0.010
HFE genotype at risk^ 13 (5) 4 (1) 3.30 (1.15–11.9) 0.025 3.53 (1.05–14.5) 0.041
Data are shown as prevalence (% value), median {interquartile range}, as required. Comparisons were made by ﬁtting data to logistic regression models.
OR: odds ratio for high vs. low CCA stiffness; CI: conﬁdence intervals.
* Adjusted for age and sex.
° per 1 log increase;
^ Deﬁned as C282Y/C282Y, C282Y/H63D, or H63D/H63D vs. H63D/wild-type and wild-type/wild-type [20].
doi:10.1371/journal.pone.0134635.t002
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Table 4. Independent predictors of elevated arterial stiffness at multivariate logistic regression analy-
sis in 568 Italian patients with essential hypertension.
OR 95% c.i. p value
Age, per 10 years 2.67 2.14–3.40 <0.001
Sex, male 2.09 1.29–3.40 0.002
BMI, Kg/m2 0.91 0.86–0.97 0.003
SBP, per 10 mmHg 1.47 1.28–1.70 <0.001
Heart rate, per 10 bpm 1.30 1.07–1.59 0.007
Hepcidin, log ng/ml 0.29 0.16–0.51 <0.001
Hyperferritinemia, yes 2.05 1.11–3.87 0.022
Comparisons were made by ﬁtting data to a logistic regression model, adjusted for age, sex, BMI, SBP,
heart rate, hepcidin levels, and presence of hyperferritinemia. OR: odds ratio; c.i.: conﬁdence interval; BMI:
body mass index; SBP: systolic blood pressure; bpm: beats per minute.
doi:10.1371/journal.pone.0134635.t004
Fig 1. Correlation between ferritin and hepcidin levels (p<0.001).
doi:10.1371/journal.pone.0134635.g001
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Hepcidin and target organ damage
In the subset of patients with available data, micro-albuminuria was higher in individuals in
the higher vs. those in the lower PWV tertile (median 5.5, IQR 1.6–12.2 vs. 3.6, IQR 0.2–9.4
mg/day; estimate 0.32±0.13; p = 0.038). At generalized linear regression, there was no signifi-
cant association between hepcidin or ferritin levels with albuminuria (p>0.1).
Cardiac function parameters stratified by PWV tertiles are shown in Table 5. Concerning
cardiac function parameters, the ejection fraction (p = 0.025), E/A ratio (p = 0.002), and S wave
peak systolic velocity (p<0.001) were lower in individuals in the higher vs. those in the lower
PWV tertile. High PWV was not significantly associated with left ventricular end diastolic
diameter, deceleration time, thickness of the inter-ventricular septum, and left ventricular mass
index (p>0.1 for all), while there was a trend for association with posterior wall thickness
(p = 0.085). At multivariate logistic regression analysis adjusted for sex and age, only S wave
peak systolic velocity remained associated with high PWV (p<0.001).
Hepcidin levels were inversely correlated with the E/A ratio (estimate per 1 log increase -0.16
±0.07; p = 0.031; S1A Fig), but not with the EF (estimate 0.44±0.14; p = 0.70) nor S wave peak
systolic velocity (estimate -1.15±0.73; p = 0.13). Ferritin levels were inversely correlated with E/
A ratio (estimate per 1 log increase -0.20±0.06; p = 0.001; S1B Fig) and S wave peak systolic
velocity (estimate -1.38±0.57; p = 0.018), but not with ejection fraction (estimate -0.04±0.92;
p = 0.97). At multivariate generalized linear model analysis (shown in S3 Table), cardiac dia-
stolic function (estimated by the E/A ratio) was negatively associated with circulating ferritin
(p = 0.006), but not with hepcidin levels (p = 0.98). No independent association was observed
between ferritin and systolic function (peak S wave velocity; not shown).
Discussion
To test whether elevated iron stores and circulating hepcidin favor the progression of athero-
sclerosis [8, 9, 11, 14], in this study we examined whether ferritin and hepcidin were associated
with aortic stiffness in a cross-sectional cohort of Italian patients with hypertension. We found
that hyperferritinemia was associated with increased, while hepcidin with decreased PWV.
The association of hyperferritinemia with increased arterial stiffness is consistent with the
hypothesis that elevated body iron stores are associated with atherosclerosis progression [9–11,
14]. Indeed, in the present cohort hyperferritinemia did not reflect subclinical inflammation.
On the other hand, hyperferritinemia is frequently observed in individuals with arterial
Table 5. Heart function parameters in 175 Italian patients with essential hypertension stratified according to common carotid arteries stiffness
(third vs. first tertile).
Stiffness
High (n = 85) Low (n = 90) OR (95% CI) p OR (95% CI)* p*
LVM index, g 110±26 105±26 1.01 (0.99–1.02) 0.23 1.01 (0.99–1.02) 0.45
IVS, cm 1.07±0.15 1.03±0.14 5.00 (0.61–43.8) 0.13 3.5 (0.30–11.1) 0.36
PWT, cm 1.00±0.13 0.96±0.12 5.50 (0.79–43.6) 0.085 2.37 (0.14–45.0) 0.54
LVEDD, cm 4.72±0.54 4.61±0.49 1.53 (0.85–2.84) 0.15 1.19 (0.57–2.45) 0.64
Ejection fraction, % 61.4±6.4 63.1±3.8 0.93 (0.86–0.99) 0.025 0.94 (0.88–1.01) 0.11
E/A, ratio 0.99±0.39 1.15±0.31 0.23 (0.08–0.61) 0.002 0.64 (0.19–1.77) 0.40
S wave peak systolic velocity, cm/s 9.6±2.7 12.5±3.4 0.73 (0.65–0.82) <0.001 0.77 (0.67–0.88) <0.001
Data are shown as prevalence (% value), median {interquartile range}, as required. Comparisons were made by ﬁtting data to logistic regression models.
OR: odds ratio for high vs. low CCA stiffness; CI: conﬁdence intervals.
* Adjusted for age and sex. LVMI: left ventricular mass; PWT: posterior wall thickness; IVS: inter-ventricular septum.
doi:10.1371/journal.pone.0134635.t005
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hypertension [10, 21], and in subjects with metabolic alterations ferritin was previously associ-
ated with increased CCA-IMT, presence of carotid plaques, and circulating CCL2 levels, a mac-
rophage chemokine involved in the progression of atherosclerosis [11, 14]. In addition, in
patients with hereditary hemochromatosis iron depletion improved radial artery thickness and
distensibility [22]. In this study, we also observed an inverse correlation between circulating
ferritin and left ventricular diastolic function (estimated by the E/A ratio), independent of
other risk factors. These results were obtained in a limited subgroup of patients with complete
characterization and should be further confirmed. However, data are consistent with the
hypothesis that increased body iron stores contribute to the pathogenesis of early diastolic dys-
function. Indeed, cardiac disease and restrictive cardiomyopathy represent a typical manifesta-
tion of body iron overload favored by oxidative stress [23].
Conversely, we observed an inverse association between circulating hepcidin and PWV.
Therefore, results do not support a role of hepcidin in determining the progression of athero-
sclerosis in large conductance vessels. This was previously hypothesized based on data suggest-
ing that hepcidin mediates iron accumulation within the arterial plaque [24], and in particular
in macrophages which phagocyte red blood cells deriving by intra-plaque hemorrhages [8, 14,
25, 26]. Hepcidin was also shown to correlate with arterial plaques in postmenopausal women
[27], to inhibit in vitro cholesterol efflux from macrophages and foam cells formation [28], and
high hepcidin predicted cardiovascular events in hemodialysis patients [29]. Furthermore, in
hemodialysis patients hepcidin has been also directly associated with increased carotid PWV
[30], and we previously reported a positive association between hepcidin levels and carotid
damage in high-risk patients [11].
On the contrary, in the present study higher hepcidin was inversely associated with aortic
stiffening, independently of the degree of iron accumulation. Differently from previous studies,
which estimated PWV of brachial arteries or focused on CCA damage, thereby evaluating
mainly resistive vessels, we specifically measured stiffness of the aorta, the major conductance
elastic artery. In keeping with the association of hepcidin with lower aortic stiffness, hepcidin
has also been reported to exert anti-inflammatory activities by inhibiting cytokine signaling
[15], possibly resulting in protection from aortic fibrosis [31]. It could be speculated that, due
to the different anatomical structure and cell composition, hepcidin has different biological
effects in the aorta as compared to resistive peripheral arteries, contributing to explain the
observed discrepancies.
Alternatively, since insulin signaling has been reported to decrease hepcidin release [32],
lower serum hepcidin in individuals with high PWVmay reflect more severe insulin resistance
in this high-risk group. Although type 2 diabetes was not associated with hepcidin levels, we
cannot rule out the aforementioned hypothesis because it was not possible to evaluate fasting
insulin levels in all patients.
Despite the relatively high number of subjects evaluated, the study is limited by the cross-
sectional design, so that we cannot exclude that hepcidin favors the formation of less stiff, but
unstable plaques resulting in increased cardiovascular risk. In addition, we could not evaluate
transferrin saturation, which is another determinant of hepcidin release, and the study was not
powered enough to correct the association of iron parameters with PWV for the use of specific
anti-hypertensive drugs. On the other hand, supporting the reliability of our findings, we
observed a strong association between hepcidin levels and serum ferritin. In addition, we vali-
dated the association of arterial stiffness with other known determinants, including age, male
sex, systolic blood pressure, and heart rate. Even if apparently counterintuitive, a negative asso-
ciation between high BMI on aortic PWV, after controlling for peripheral SBP, has previously
been reported [33, 34]. This “protective” effect of overweight on aortic stiffness was related to
modification of aortic walls, different mechanisms of adaptation to increased blood pressure,
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or volume overload. Furthermore, obesity has also been previously associated with increased
brachial artery compliance in young normotensive subjects [35]. This finding indicates that
not all risk factors for vascular events, possibly including high hepcidin levels, are invariably
associated with increased aortic stiffness.
In conclusion, hyperferritinemia is associated with high aortic stiffness and cardiac diastolic
dysfunction (E/A ratio), and low circulating hepcidin is associated with high aortic stiffness.
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